Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biomolecules ; 13(2)2023 01 18.
Article in English | MEDLINE | ID: mdl-36830566

ABSTRACT

2-naphthol is a low-molecular-weight (LMW) polycyclic aromatic hydrocarbon (PAH) and air pollutant associated with childhood obesity. There has been a recent emergence of studies on the consequences of PAHs on human health. Current epidemiological reports suggest LMW-PAHs may contribute to obesity incidences in children, yet most studies focus on high-molecular-weight PAHs. This study explores 2-naphthol's impact on obesity and obesity-associated metabolic disorders. To investigate 2-naphthol's effect on lipid metabolism and inflammation, we employed 3T3-L1 and BAT1 cell lines to model white and brown adipocytes, respectively, alongside a murine macrophage cell line (RAW264.7). We found that 2-naphthol increased the expression of key adipogenic and lipogenic genes while decreasing lipolytic gene expression in chronically treated 3T3-L1 and BAT1 adipocytes. In addition, chronic 2-naphthol treatment also suppressed adrenergic-stimulated thermogenic gene expression in BAT1 brown adipocytes. In consistence, an increase in lipid accumulation was demonstrated in BODIPY and Oil Red O-stained adipocytes. Additionally, 3T3-L1 adipocytes and RAW264.7 macrophages chronically exposed to 2-naphthol showed upregulated mRNA expression of major inflammatory cytokines (e.g., tumor necrosis factor α (Tnfα), interleukin-1ß (Il-1ß), and Il-6). In summary, chronic exposure to 2-naphthol stimulates lipid accumulation in adipocytes and inflammation in adipocytes and macrophages. These findings support previous research that demonstrates 2-naphthol has obesogenic potential.


Subject(s)
Pediatric Obesity , Child , Humans , Animals , Mice , Inflammation , Adipocytes, Brown , Lipids
2.
Nat Commun ; 12(1): 6838, 2021 11 25.
Article in English | MEDLINE | ID: mdl-34824202

ABSTRACT

Brown adipocytes share the same developmental origin with skeletal muscle. Here we find that a brown adipocyte-to-myocyte remodeling also exists in mature brown adipocytes, and is induced by prolonged high fat diet (HFD) feeding, leading to brown fat dysfunction. This process is regulated by the interaction of epigenetic pathways involving histone and DNA methylation. In mature brown adipocytes, the histone demethylase UTX maintains persistent demethylation of the repressive mark H3K27me3 at Prdm16 promoter, leading to high Prdm16 expression. PRDM16 then recruits DNA methyltransferase DNMT1 to Myod1 promoter, causing Myod1 promoter hypermethylation and suppressing its expression. The interaction between PRDM16 and DNMT1 coordinately serves to maintain brown adipocyte identity while repressing myogenic remodeling in mature brown adipocytes, thus promoting their active brown adipocyte thermogenic function. Suppressing this interaction by HFD feeding induces brown adipocyte-to-myocyte remodeling, which limits brown adipocyte thermogenic capacity and compromises diet-induced thermogenesis, leading to the development of obesity.


Subject(s)
Adipose Tissue, Brown/pathology , DNA (Cytosine-5-)-Methyltransferase 1/metabolism , Diet, High-Fat/adverse effects , Epigenesis, Genetic , Histone Demethylases/metabolism , Muscle Development/genetics , Adipocytes, Brown/metabolism , Adipocytes, Brown/pathology , Adipose Tissue, Brown/metabolism , Adiposity/genetics , Animals , DNA (Cytosine-5-)-Methyltransferase 1/deficiency , DNA Methylation , DNA Methyltransferase 3A/deficiency , DNA Methyltransferase 3A/metabolism , DNA-Binding Proteins/metabolism , Gene Silencing , Histone Demethylases/deficiency , Mice , Mice, Knockout , MyoD Protein/genetics , MyoD Protein/metabolism , Myogenic Regulatory Factor 5/metabolism , Obesity/etiology , Obesity/genetics , Obesity/metabolism , Obesity/pathology , Promoter Regions, Genetic , Thermogenesis/genetics , Transcription Factors/metabolism , Weight Gain/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...